Citizen Portal
Sign In

Lifetime Citizen Portal Access — AI Briefings, Alerts & Unlimited Follows

Committee advances bill to classify new fentanyl‑enhancing chemicals as controlled substances

Oklahoma Senate Health and Human Services Committee · April 13, 2026

Loading...

AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

House Bill 37 67, introduced to add 14 chemicals used to enhance street fentanyl to Oklahoma's controlled substances schedules, was advanced by the Senate Health and Human Services Committee after agency testimony clarified drafting and dispenser definitions; committee vote was 10–0.

The Oklahoma Senate Health and Human Services Committee advanced House Bill 37 67 (HB 3767) to add 14 unregulated chemicals — described in the bill as used to enhance the effects of street fentanyl — to the state's controlled substances schedules.

Senator Yek, the bill's sponsor, told the committee the chemicals are new black-market additives with sedative effects when mixed with fentanyl and that placing them on the schedule would give law enforcement and regulators tools to address harms.

Senator Hicks asked for clarification about a drafting change on page 37 that expands the definition of "dispenser" to include those handling schedule 3, 4 or 5 substances. Mark Woodward of the Oklahoma Bureau (OBN) explained the change aims to align state language with federal scheduling and to avoid categorizing chemicals as Schedule I when they may have legitimate medical uses. "We followed basically other states and the federal government ... to make sure our location whether it's a schedule 4 drug or a schedule 2, aligns with the existing federal law," Woodward said.

After limited questioning and no debate, the committee recorded 10 ayes and 0 nays and advanced the bill's relevant section.

Why it matters: the change targets emerging additives that can increase overdose risk or alter fentanyl's effects; the committee heard agency rationale aimed at balancing medical availability with street diversion prevention.